Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?


OverviewForecastFinancialsChart

Reviva Pharmaceuticals Ownership Summary


Reviva Pharmaceuticals is owned by 0.11% institutional investors, 7.73% insiders, and 92.16% retail investors. Diadema partners lp is the largest institutional shareholder, holding 5.03% of RVPH shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.50% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals0.11%7.73%92.16%
SectorHealthcare Stocks 244.37%12.11%-156.48%
IndustryBiotech Stocks 379.01%11.75%-290.76%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Diadema partners lp2.51M5.03%$924.05K
Vanguard group3.20M4.40%$892.13K
Persistent asset partners593.90K1.19%$218.91K
Susquehanna group, llp202.01K0.60%$365.64K
Blackrock102.93K0.43%$131.75K
Avantax advisory services57.50K0.17%$21.91K
Citadel advisors41.50K0.17%$53.12K
Pale fire capital se25.00K0.10%$32.00K
Schonfeld strategic advisors48.42K0.10%$17.85K
Emc capital management6.70K0.10%$3.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Diadema partners lp2.51M0.24%$924.05K
Persistent asset partners593.90K0.15%$218.91K
Pale fire capital se25.00K0.00%$32.00K
Nri wealth management lc11.38K0.00%$3.17K
Emc capital management6.70K0.00%$3.00K
Avantax advisory services57.50K0.00%$21.91K
Susquehanna group, llp202.01K0.00%$365.64K
Schonfeld strategic advisors48.42K0.00%$17.85K
Marshall wace, llp---
Renaissance---

Top Buyers

HolderShares% AssetsChange
Vanguard group3.20M-1.27M
Susquehanna group, llp202.01K0.00%138.84K
Wolverine trading14.26K-14.26K
Blackrock102.93K-11.07K
Emc capital management6.70K0.00%6.70K

Top Sellers

HolderShares% AssetsChange
Heights capital management---1.83M
683 capital management---1.00M
Jane street group---894.75K
Millennium management---793.95K
Jpmorgan chase---762.24K

New Positions

HolderShares% AssetsChangeValue
Wolverine trading14.26K-14.26K$25.81K
Emc capital management6.70K0.00%6.70K$3.00K
Mosley wealth management1.00-1.00$1.00

Sold Out

HolderChange
Danske bank-7.00
Tradewinds capital management-13.00
Qube research-50.00
Activest wealth management-50.00
Vermillion wealth management-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20265-86.49%7,728-99.79%-0.00%3-80.00%--100.00%
Mar 31, 202628-47.17%2,184,824-80.40%3113.18%12-55.56%1427.27%
Dec 31, 202538-19.15%8,136,283-14.17%113.10%2011.11%7-36.36%
Sep 30, 202543-12.24%9,324,158-34.68%181.01%17-22.73%1011.11%
Jun 30, 202551-3.77%14,278,36798.90%439.18%22-21.43%9-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF700.44K1.50%-
Vanguard Total Stock Mkt Idx Inv59.61K1.01%-
Vanguard Institutional Extnd Mkt Idx Tr57.96K0.99%-
BlackRock Extended Equity Market Fund K27.25K0.46%-289.49K
Fidelity Extended Market Index41.49K0.32%-152.00
Blackrock Extended Mkt Fund CF18.46K0.31%1.00
Abante Quant Value FI345.41K0.29%-
Extended Equity Market Fund K27.25K0.21%-289.49K
Northern Trust Extended Eq Market Idx9.17K0.16%-39.70K
NT Ext Equity Mkt Index Fund - Lending9.17K0.16%-174.21K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q1--
2024 Q4--
2024 Q3--

RVPH Ownership FAQ


Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 0.11%, followed by 7.73% insiders and 92.16% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 379.01%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Diadema partners lp (2.51M shares, 5.03%), Vanguard group (3.2M shares, 4.40%), and Persistent asset partners (593.9K shares, 1.19%). Together, they hold 10.62% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

Yes, BlackRock owns 0.43% of Reviva Pharmaceuticals, totaling 102.93K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 131.75K$. In the last quarter, BlackRock increased its holdings by 11.07K shares, a 12.05% change.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Diadema partners lp is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 2.51M Reviva Pharmaceuticals shares, valued at 924.05K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Reviva Pharmaceuticals shares, with 1.50% of its total shares outstanding invested in 700.44K Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools